Anlon Healthcare Share Price
26.66+1.26 (+4.96%)
+91.43% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
LAURUSLABSNSE
ZYDUSLIFENSE
DRREDDYNSE
CIPLANSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
AHCLNSE
Anlon Healthcare Share Price
26.66+1.26 (+4.96%)
+91.43% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | - | 43% |
| - | - | - | 42% |
| - | - | - | 91% |
| 22% | 22% | 22% | 19% |
Peer Comparison
Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
LAURUSLABS
ZYDUSLIFE
DRREDDY
CIPLA
MANKIND
AUROPHARMA
LUPIN
AHCL
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,773.4 | ₹425150 Cr | 38.77 | 8.29 | 58.23 | ₹11479 Cr |
| 10,037.5 | ₹266265 Cr | 91.03 | 34.04 | 128.41 | ₹2568 Cr |
| 4,738.5 | ₹176301 Cr | 83 | 14.04 | 106.21 | ₹2163 Cr |
| 2,323.8 | ₹125352 Cr | 93.56 | 8.17 | 33.94 | ₹889 Cr |
| 1,188.1 | ₹123591 Cr | 27.39 | 9.42 | 62.53 | ₹5040 Cr |
| 1,374 | ₹114351 Cr | 40.84 | 11.08 | 59.2 | ₹4196 Cr |
| 1,402 | ₹112474 Cr | 38.82 | 10.86 | 52.6 | ₹3879 Cr |
| 2,537.9 | ₹102315 Cr | 45.62 | 17.23 | 76.26 | ₹1913 Cr |
| 1,705 | ₹97757 Cr | 26.33 | 17.95 | 96.84 | ₹3505 Cr |
| 2,008.6 | ₹92007 Cr | 16.64 | 30.95 | 154.35 | ₹5333 Cr |
| 26.66 | ₹1349 Cr | 47.31 | 0.25 | 0.57 | ₹29 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Sep 2026 | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| ₹106 Cr | ₹88 Cr | ₹51 Cr | ₹52 Cr | ₹33 Cr | ₹49 Cr |
| ₹5 L | ₹6 L | ₹1 L | ₹3 L | ₹1 L | ₹4 L |
| ₹106 Cr | ₹88 Cr | ₹51 Cr | ₹52 Cr | ₹33 Cr | ₹49 Cr |
| ₹81 Cr | ₹73 Cr | ₹36 Cr | ₹39 Cr | ₹27 Cr | ₹33 Cr |
| ₹25 Cr | ₹16 Cr | ₹15 Cr | ₹14 Cr | ₹6 Cr | ₹17 Cr |
| ₹86 L | ₹93 L | ₹57 L | ₹84 L | ₹82 L | ₹91 L |
| ₹23 Cr | ₹14 Cr | ₹14 Cr | ₹12 Cr | ₹5 Cr | ₹15 Cr |
| ₹17 Cr | ₹8 Cr | ₹11 Cr | ₹9 Cr | ₹4 Cr | ₹17 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 |
|---|---|
| — | — |
| ₹53 Cr | ₹40 Cr |
| ₹177 Cr | ₹41 Cr |
| ₹177 Cr | ₹41 Cr |
| ₹230 Cr | ₹80 Cr |
| ₹25 Cr | ₹0 |
| ₹6 Cr | ₹5 Cr |
| ₹4 L | ₹34 Cr |
| ₹5 Cr | ₹2 Cr |
| ₹37 L | ₹24 L |
| ₹12 Cr | ₹41 Cr |
| — | — |
| ₹42 Cr | ₹20 Cr |
| ₹14 Cr | ₹4 Cr |
| ₹38 Cr | ₹28 Cr |
| ₹14 Cr | ₹8 Cr |
| ₹108 Cr | ₹60 Cr |
| ₹374 Cr | ₹181 Cr |
| ₹25 L | ₹0 |
| ₹44 Cr | ₹67 Cr |
| — | — |
| ₹84 Cr | ₹36 Cr |
| ₹26 Cr | ₹13 Cr |
| ₹58 Cr | ₹23 Cr |
| ₹98 L | ₹0 |
| ₹98 L | ₹0 |
| ₹7 Cr | ₹0 |
| ₹66 Cr | ₹23 Cr |
| — | — |
| ₹1 L | ₹91 L |
| ₹113 Cr | ₹50 Cr |
| ₹104 Cr | ₹75 Cr |
| ₹4 Cr | ₹1 Cr |
| ₹1 Cr | ₹1 Cr |
| ₹86 Cr | ₹30 Cr |
| ₹308 Cr | ₹158 Cr |
| ₹201 Cr | ₹98 Cr |
| ₹374 Cr | ₹181 Cr |
| ₹43 | ₹20 |
| ₹4 | ₹2 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 |
|---|---|
| ₹43 Cr | ₹27 Cr |
| ₹5 Cr | -₹56 L |
| -₹122 Cr | -₹54 Cr |
| -₹75 Cr | -₹28 Cr |
| -₹79 Cr | -₹23 Cr |
| -₹36 Cr | ₹3 Cr |
| ₹119 Cr | ₹19 Cr |
| ₹3 Cr | -₹82 L |
| ₹1 Cr | ₹2 Cr |
| ₹4 Cr | ₹1 Cr |
Fundamental Ratios
Consolidated
Standalone
No results found
Anlon Healthcare Share Price
26.66+1.26 (+4.96%)
+91.43% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 3
Bearish signals: 2 out of 9 oscillators
RSI
53.01Neutral
STOCH %K
64.94Neutral
MACD Level(12,26)
-0.06Sell
Ultimate Oscillator
50.68Buy
Aroon Oscillator
54.00Buy
BOP
0.81Buy
CCI
-18.79Neutral
Williams %R
-35.06Neutral
Momentum
-2.38Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 8
Bearish signals: 1 out of 9 moving averages
EMA 9
25.68Buy
SMA 9
25.21Buy
EMA 21
26.06Buy
SMA 21
26.67Sell
EMA 50
24.18Buy
SMA 50
23.99Buy
EMA 200
18.06Buy
SMA 200
16.21Buy
WMA 20
25.83Buy
Pivot
Pivot
Classic
Resistance 5
29.52
Resistance 4
28.49
Resistance 3
27.46
Resistance 2
26.43
Resistance 1
25.92
Pivot
25.40
Support 1
24.89
Support 2
24.37
Support 3
23.34
Support 4
22.31
Support 5
21.28
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Anlon Healthcare Share Price
26.66+1.26 (+4.96%)
+91.43% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| 52.68% | 52.68% | 52.68% | 52.68% | 52.68% |
| 0.99% | 1.67% | 0.32% | 0.23% | 0.00% |
| 0.30% | 1.23% | 4.60% | 4.49% | 2.83% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 46.03% | 44.42% | 42.40% | 42.60% | 44.49% |
Bulk & block deals
Name
Neo Apex Share Broking Services Llp
Neo Apex Share Broking Services Llp
Neo Apex Share Broking Services Llp
Neo Apex Share Broking Services Llp
Neo Apex Share Broking Services Llp
Neo Apex Share Broking Services Llp
Neo Apex Share Broking Services Llp
Neo Apex Share Broking Services Llp
Junomoneta Finsol Private Limited
Nk Securities Research Private Limited
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 08 Oct 2026 | Sell | 16.81 Cr | ₹26.81 | 62.72 L | Bulk | 11.799347 | NSE |
| 08 Oct 2026 | Purchase | 14.51 Cr | ₹26.78 | 54.17 L | Bulk | 10.191923 | NSE |
| 06 Oct 2026 | Purchase | 17.40 Cr | ₹29.70 | 58.59 L | Bulk | 11.022276 | NSE |
| 06 Oct 2026 | Sell | 4.23 Cr | ₹29.76 | 14.21 L | Bulk | 2.673815 | NSE |
| 30 Sep 2026 | Sell | 9.35 Cr | ₹34.62 | 27.02 L | Bulk | 5.083 | NSE |
| 30 Sep 2026 | Purchase | 18.05 Cr | ₹34.66 | 52.09 L | Bulk | 9.800041 | NSE |
| 29 Sep 2026 | Sell | 10.01 Cr | ₹36.39 | 27.50 L | Bulk | 5.17389 | NSE |
| 29 Sep 2026 | Purchase | 6.37 Cr | ₹36.39 | 17.50 L | Bulk | 3.292475 | NSE |
| 25 Sep 2026 | Sell | 9.69 Cr | ₹30.16 | 32.13 L | Bulk | 6.044783 | NSE |
| 25 Sep 2026 | Sell | 9.94 Cr | ₹30.15 | 32.98 L | Bulk | 6.205719 | NSE |
Insider trading & SAST
Client name
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|
Anlon Healthcare Share Price
26.66+1.26 (+4.96%)
+91.43% past 1 Year
Anlon Healthcare is a chemical manufacturing company, engaged in manufacturing of pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs), which are supplied to customers both in India and international markets. Its
Corporate Actions
Date
Type
Details
Company details
Anlon Healthcare Share Price
26.66+1.26 (+4.96%)
+91.43% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Anlon Healthcare Share Price
26.66+1.26 (+4.96%)
+91.43% past 1 Year
News
Anlon Healthcare Reports Higher Second Quarter EBITDA With Lower Margin
Equity
AHCL
AHCL Q2 standalone net profit declines year on year
Equity
AHCL
Anlon Healthcare Reports Stronger Second Quarter Revenue Growth
Equity
AHCL
Anlon Healthcare Approves Convertible Warrants Issue Worth Up To Rs 250 Crores
Equity
AHCL
AHCL reports Rs 20.54 crores NSE block trade involving 6,870,493 shares
Equity
AHCL
Anlon Healthcare guides for 30 percent revenue CAGR over next three years
Equity
AHCL
Anlon Healthcare Q1 revenue declines year-on-year, modest topline pressure observed
Equity
AHCL
Anlon Healthcare reports higher Q1 EBITDA and improved margin year on year
Equity
AHCL
Anlon Healthcare Q1 net profit rises year-on-year to Rs 4.80 crores
Equity
AHCL
Anlon Healthcare informs about invitation for tv interview
Equity
AHCL
Anlon Healthcare informs about conference call
Equity
AHCL
Anlon Healthcare informs about press release
Equity
AHCL
Anlon Healthcare informs about newspaper advertisement
Equity
AHCL
Anlon Healthcare informs about press release
Equity
AHCL
Anlon Healthcare reports Profit after tax of 9.79 Crores, in the March 2026 quarter
Equity
AHCL
Anlon Healthcare Q4 EBITDA declines with significant compression in margins YoY
Equity
AHCL
Anlon Healthcare Q4 reports year-on-year revenue growth for FY2024 period
Equity
AHCL
Anlon Healthcare reports lower Q4 net profit year on year
Equity
AHCL
Anlon Healthcare informs about allotment of bonus equity shares
Equity
AHCL
Anlon Healthcare informs about share purchase agreement
Equity
AHCL